# Event Schema Specifications

**Version:** 1.0.0
**Last Updated:** 2025-12-07
**System:** Biotech M&A Predictor

---

## Table of Contents

1. [Overview](#overview)
2. [Message Envelope Format](#message-envelope-format)
3. [Event Schemas](#event-schemas)
   - [ClinicalTrialSignalEvent](#clinicaltrialsignalevent)
   - [PatentCliffEvent](#patentcliffevent)
   - [InsiderActivityEvent](#insideractivityevent)
   - [HiringSignalEvent](#hiringsignalevent)
   - [MACandidateEvent](#macandidateevent)
   - [AcquirerMatchEvent](#acquirermatchevent)
   - [ReportGeneratedEvent](#reportgeneratedevent)
4. [Validation Rules](#validation-rules)
5. [Event Flow](#event-flow)

---

## Overview

This document defines the event schemas used in the biotech M&A predictor system. All events flow through a common event bus and adhere to a standard message envelope format. Events are produced by three primary signal sources:

- **Clinical Trial Signals**: Trial outcomes, phase progressions, trial terminations
- **Patent IP Intelligence**: Patent expirations, generic entry threats, IP landscape changes
- **Insider & Hiring Signals**: Form 4/13F filings, executive movements, key hiring activities

These signals are processed to generate M&A candidate predictions and acquirer-target matches.

---

## Message Envelope Format

All events published to the event bus MUST be wrapped in a standard message envelope.

### Schema

```json
{
  "$schema": "http://json-schema.org/draft-07/schema#",
  "type": "object",
  "required": [
    "envelope_version",
    "event_id",
    "event_type",
    "event_version",
    "source",
    "timestamp",
    "payload"
  ],
  "properties": {
    "envelope_version": {
      "type": "string",
      "description": "Version of the envelope schema",
      "pattern": "^\\d+\\.\\d+\\.\\d+$",
      "example": "1.0.0"
    },
    "event_id": {
      "type": "string",
      "description": "Unique identifier for this event instance (UUID v4)",
      "pattern": "^[0-9a-f]{8}-[0-9a-f]{4}-4[0-9a-f]{3}-[89ab][0-9a-f]{3}-[0-9a-f]{12}$",
      "example": "550e8400-e29b-41d4-a716-446655440000"
    },
    "event_type": {
      "type": "string",
      "description": "Type of event being published",
      "enum": [
        "ClinicalTrialSignalEvent",
        "PatentCliffEvent",
        "InsiderActivityEvent",
        "HiringSignalEvent",
        "MACandidateEvent",
        "AcquirerMatchEvent",
        "ReportGeneratedEvent"
      ]
    },
    "event_version": {
      "type": "string",
      "description": "Version of the event schema",
      "pattern": "^\\d+\\.\\d+\\.\\d+$",
      "example": "1.0.0"
    },
    "source": {
      "type": "string",
      "description": "Service/component that produced this event",
      "example": "clinical-trial-signals"
    },
    "timestamp": {
      "type": "string",
      "format": "date-time",
      "description": "ISO 8601 timestamp when event was created",
      "example": "2025-12-07T14:32:15.123Z"
    },
    "correlation_id": {
      "type": "string",
      "description": "Optional ID to correlate related events across services",
      "pattern": "^[0-9a-f]{8}-[0-9a-f]{4}-4[0-9a-f]{3}-[89ab][0-9a-f]{3}-[0-9a-f]{12}$"
    },
    "causation_id": {
      "type": "string",
      "description": "Optional ID of the event that directly caused this event",
      "pattern": "^[0-9a-f]{8}-[0-9a-f]{4}-4[0-9a-f]{3}-[89ab][0-9a-f]{3}-[0-9a-f]{12}$"
    },
    "metadata": {
      "type": "object",
      "description": "Optional metadata for tracking, debugging, or routing",
      "properties": {
        "retry_count": {
          "type": "integer",
          "minimum": 0
        },
        "priority": {
          "type": "string",
          "enum": ["low", "medium", "high", "critical"]
        },
        "tags": {
          "type": "array",
          "items": {
            "type": "string"
          }
        }
      }
    },
    "payload": {
      "type": "object",
      "description": "The actual event data (schema varies by event_type)"
    }
  }
}
```

### Example Envelope

```json
{
  "envelope_version": "1.0.0",
  "event_id": "550e8400-e29b-41d4-a716-446655440000",
  "event_type": "ClinicalTrialSignalEvent",
  "event_version": "1.0.0",
  "source": "clinical-trial-signals",
  "timestamp": "2025-12-07T14:32:15.123Z",
  "correlation_id": "660e8400-e29b-41d4-a716-446655440111",
  "metadata": {
    "priority": "high",
    "tags": ["phase3", "oncology"]
  },
  "payload": {
    "...": "event-specific data"
  }
}
```

---

## Event Schemas

### ClinicalTrialSignalEvent

Emitted when significant changes occur in clinical trial status, outcomes, or phase progressions.

#### Schema Version: 1.0.0

```json
{
  "$schema": "http://json-schema.org/draft-07/schema#",
  "type": "object",
  "required": [
    "company_id",
    "company_name",
    "trial_id",
    "trial_nct_id",
    "drug_name",
    "indication",
    "signal_type",
    "current_phase",
    "signal_date",
    "impact_score"
  ],
  "properties": {
    "company_id": {
      "type": "string",
      "description": "Unique identifier for the company",
      "example": "COMP-12345"
    },
    "company_name": {
      "type": "string",
      "description": "Name of the biotech company",
      "example": "Acme Therapeutics Inc."
    },
    "ticker_symbol": {
      "type": "string",
      "description": "Stock ticker symbol (if publicly traded)",
      "pattern": "^[A-Z]{1,5}$",
      "example": "ACME"
    },
    "trial_id": {
      "type": "string",
      "description": "Internal trial identifier",
      "example": "TRIAL-98765"
    },
    "trial_nct_id": {
      "type": "string",
      "description": "ClinicalTrials.gov NCT identifier",
      "pattern": "^NCT\\d{8}$",
      "example": "NCT04123456"
    },
    "drug_name": {
      "type": "string",
      "description": "Name of the drug/therapeutic being tested",
      "example": "ACM-2001"
    },
    "indication": {
      "type": "string",
      "description": "Medical condition being treated",
      "example": "Non-Small Cell Lung Cancer"
    },
    "therapeutic_area": {
      "type": "string",
      "description": "Broader therapeutic category",
      "enum": [
        "oncology",
        "neurology",
        "cardiovascular",
        "immunology",
        "rare_disease",
        "metabolic",
        "infectious_disease",
        "other"
      ],
      "example": "oncology"
    },
    "signal_type": {
      "type": "string",
      "description": "Type of clinical trial signal detected",
      "enum": [
        "phase_advancement",
        "phase_failure",
        "trial_termination",
        "positive_interim",
        "negative_interim",
        "enrollment_completion",
        "primary_endpoint_met",
        "primary_endpoint_missed",
        "regulatory_breakthrough",
        "fda_fast_track",
        "orphan_designation"
      ],
      "example": "phase_advancement"
    },
    "current_phase": {
      "type": "string",
      "description": "Current trial phase",
      "enum": ["preclinical", "phase1", "phase2", "phase3", "phase4", "post_market"],
      "example": "phase3"
    },
    "previous_phase": {
      "type": "string",
      "description": "Previous trial phase (for phase changes)",
      "enum": ["preclinical", "phase1", "phase2", "phase3", "phase4"],
      "example": "phase2"
    },
    "signal_date": {
      "type": "string",
      "format": "date",
      "description": "Date when the signal was detected",
      "example": "2025-12-01"
    },
    "impact_score": {
      "type": "number",
      "description": "Calculated impact score (0-100) indicating M&A relevance",
      "minimum": 0,
      "maximum": 100,
      "example": 87.5
    },
    "patient_enrollment": {
      "type": "integer",
      "description": "Number of patients enrolled",
      "minimum": 0,
      "example": 450
    },
    "primary_endpoints": {
      "type": "array",
      "description": "Primary endpoints being measured",
      "items": {
        "type": "string"
      },
      "example": ["Overall Survival", "Progression-Free Survival"]
    },
    "trial_status": {
      "type": "string",
      "description": "Current trial status",
      "enum": [
        "recruiting",
        "active_not_recruiting",
        "completed",
        "terminated",
        "suspended",
        "withdrawn"
      ],
      "example": "active_not_recruiting"
    },
    "estimated_completion_date": {
      "type": "string",
      "format": "date",
      "description": "Estimated primary completion date",
      "example": "2026-06-30"
    },
    "data_source": {
      "type": "string",
      "description": "Source of the clinical trial data",
      "example": "ClinicalTrials.gov"
    },
    "url": {
      "type": "string",
      "format": "uri",
      "description": "URL to trial information",
      "example": "https://clinicaltrials.gov/study/NCT04123456"
    },
    "notes": {
      "type": "string",
      "description": "Additional context or observations",
      "maxLength": 1000
    }
  }
}
```

#### Example Payload

```json
{
  "company_id": "COMP-12345",
  "company_name": "Acme Therapeutics Inc.",
  "ticker_symbol": "ACME",
  "trial_id": "TRIAL-98765",
  "trial_nct_id": "NCT04123456",
  "drug_name": "ACM-2001",
  "indication": "Non-Small Cell Lung Cancer",
  "therapeutic_area": "oncology",
  "signal_type": "phase_advancement",
  "current_phase": "phase3",
  "previous_phase": "phase2",
  "signal_date": "2025-12-01",
  "impact_score": 87.5,
  "patient_enrollment": 450,
  "primary_endpoints": [
    "Overall Survival",
    "Progression-Free Survival"
  ],
  "trial_status": "active_not_recruiting",
  "estimated_completion_date": "2026-06-30",
  "data_source": "ClinicalTrials.gov",
  "url": "https://clinicaltrials.gov/study/NCT04123456",
  "notes": "Phase 3 advancement following successful interim analysis showing 40% improvement in PFS"
}
```

---

### PatentCliffEvent

Emitted when patent expirations, generic entry threats, or significant IP landscape changes are detected.

#### Schema Version: 1.0.0

```json
{
  "$schema": "http://json-schema.org/draft-07/schema#",
  "type": "object",
  "required": [
    "company_id",
    "company_name",
    "drug_name",
    "patent_number",
    "event_type",
    "expiration_date",
    "threat_level",
    "impact_score"
  ],
  "properties": {
    "company_id": {
      "type": "string",
      "description": "Unique identifier for the company",
      "example": "COMP-12345"
    },
    "company_name": {
      "type": "string",
      "description": "Name of the company holding the patent",
      "example": "Acme Therapeutics Inc."
    },
    "ticker_symbol": {
      "type": "string",
      "description": "Stock ticker symbol (if publicly traded)",
      "pattern": "^[A-Z]{1,5}$",
      "example": "ACME"
    },
    "drug_name": {
      "type": "string",
      "description": "Name of the drug/product protected by patent",
      "example": "ACM-2001"
    },
    "patent_number": {
      "type": "string",
      "description": "Patent number (jurisdiction-specific format)",
      "example": "US10123456B2"
    },
    "patent_title": {
      "type": "string",
      "description": "Title of the patent",
      "example": "Method and composition for treating NSCLC"
    },
    "patent_type": {
      "type": "string",
      "description": "Type of patent protection",
      "enum": [
        "composition_of_matter",
        "method_of_use",
        "formulation",
        "process",
        "combination",
        "other"
      ],
      "example": "composition_of_matter"
    },
    "event_type": {
      "type": "string",
      "description": "Type of patent cliff event",
      "enum": [
        "expiration_imminent",
        "expiration_occurred",
        "generic_challenge",
        "anda_filing",
        "paragraph_iv_certification",
        "patent_invalidation",
        "loss_of_exclusivity",
        "extension_granted",
        "extension_denied"
      ],
      "example": "expiration_imminent"
    },
    "expiration_date": {
      "type": "string",
      "format": "date",
      "description": "Patent expiration date",
      "example": "2026-03-15"
    },
    "filing_date": {
      "type": "string",
      "format": "date",
      "description": "Original patent filing date",
      "example": "2006-03-15"
    },
    "jurisdiction": {
      "type": "string",
      "description": "Jurisdiction where patent is registered",
      "enum": ["US", "EU", "JP", "CN", "CA", "IN", "BR", "OTHER"],
      "example": "US"
    },
    "threat_level": {
      "type": "string",
      "description": "Level of threat to revenue",
      "enum": ["critical", "high", "medium", "low"],
      "example": "critical"
    },
    "impact_score": {
      "type": "number",
      "description": "Calculated impact score (0-100) indicating M&A relevance",
      "minimum": 0,
      "maximum": 100,
      "example": 92.0
    },
    "days_until_expiration": {
      "type": "integer",
      "description": "Number of days until patent expires",
      "minimum": 0,
      "example": 98
    },
    "annual_revenue_at_risk": {
      "type": "number",
      "description": "Estimated annual revenue at risk (USD millions)",
      "minimum": 0,
      "example": 450.5
    },
    "revenue_percentage": {
      "type": "number",
      "description": "Percentage of company revenue from this product",
      "minimum": 0,
      "maximum": 100,
      "example": 67.5
    },
    "generic_competitors": {
      "type": "array",
      "description": "Known generic competitors or ANDA filers",
      "items": {
        "type": "object",
        "properties": {
          "company_name": {
            "type": "string"
          },
          "filing_date": {
            "type": "string",
            "format": "date"
          },
          "status": {
            "type": "string"
          }
        }
      }
    },
    "exclusivity_extensions": {
      "type": "array",
      "description": "Any exclusivity extensions (pediatric, orphan, etc.)",
      "items": {
        "type": "object",
        "properties": {
          "extension_type": {
            "type": "string"
          },
          "extension_date": {
            "type": "string",
            "format": "date"
          },
          "additional_months": {
            "type": "integer"
          }
        }
      }
    },
    "related_patents": {
      "type": "array",
      "description": "Related patent numbers in the patent family",
      "items": {
        "type": "string"
      },
      "example": ["US10987654B2", "EP2345678A1"]
    },
    "data_source": {
      "type": "string",
      "description": "Source of patent information",
      "example": "USPTO, Orange Book"
    },
    "url": {
      "type": "string",
      "format": "uri",
      "description": "URL to patent details",
      "example": "https://patents.google.com/patent/US10123456B2"
    },
    "notes": {
      "type": "string",
      "description": "Additional context or observations",
      "maxLength": 1000
    }
  }
}
```

#### Example Payload

```json
{
  "company_id": "COMP-12345",
  "company_name": "Acme Therapeutics Inc.",
  "ticker_symbol": "ACME",
  "drug_name": "ACM-2001",
  "patent_number": "US10123456B2",
  "patent_title": "Method and composition for treating NSCLC",
  "patent_type": "composition_of_matter",
  "event_type": "expiration_imminent",
  "expiration_date": "2026-03-15",
  "filing_date": "2006-03-15",
  "jurisdiction": "US",
  "threat_level": "critical",
  "impact_score": 92.0,
  "days_until_expiration": 98,
  "annual_revenue_at_risk": 450.5,
  "revenue_percentage": 67.5,
  "generic_competitors": [
    {
      "company_name": "Generic Pharma Corp",
      "filing_date": "2025-09-15",
      "status": "Paragraph IV certification filed"
    }
  ],
  "exclusivity_extensions": [],
  "related_patents": ["US10987654B2", "EP2345678A1"],
  "data_source": "USPTO, Orange Book",
  "url": "https://patents.google.com/patent/US10123456B2",
  "notes": "Critical revenue driver with no pipeline replacement. High M&A vulnerability."
}
```

---

### InsiderActivityEvent

Emitted when significant insider trading activity or institutional investor movements are detected via Form 4 or 13F filings.

#### Schema Version: 1.0.0

```json
{
  "$schema": "http://json-schema.org/draft-07/schema#",
  "type": "object",
  "required": [
    "company_id",
    "company_name",
    "activity_type",
    "filing_type",
    "filing_date",
    "transaction_date",
    "impact_score"
  ],
  "properties": {
    "company_id": {
      "type": "string",
      "description": "Unique identifier for the company",
      "example": "COMP-12345"
    },
    "company_name": {
      "type": "string",
      "description": "Name of the company",
      "example": "Acme Therapeutics Inc."
    },
    "ticker_symbol": {
      "type": "string",
      "description": "Stock ticker symbol",
      "pattern": "^[A-Z]{1,5}$",
      "example": "ACME"
    },
    "activity_type": {
      "type": "string",
      "description": "Type of insider activity",
      "enum": [
        "insider_buy",
        "insider_sell",
        "institutional_buy",
        "institutional_sell",
        "institutional_new_position",
        "institutional_exit",
        "option_exercise",
        "stock_award"
      ],
      "example": "insider_buy"
    },
    "filing_type": {
      "type": "string",
      "description": "SEC filing type",
      "enum": ["form_4", "form_13f", "form_13d", "form_13g"],
      "example": "form_4"
    },
    "filing_date": {
      "type": "string",
      "format": "date",
      "description": "Date when filing was submitted to SEC",
      "example": "2025-12-05"
    },
    "transaction_date": {
      "type": "string",
      "format": "date",
      "description": "Date when transaction occurred",
      "example": "2025-12-03"
    },
    "insider_name": {
      "type": "string",
      "description": "Name of the insider (for Form 4)",
      "example": "John Smith"
    },
    "insider_title": {
      "type": "string",
      "description": "Title/role of the insider",
      "example": "Chief Executive Officer"
    },
    "insider_relationship": {
      "type": "string",
      "description": "Relationship to company",
      "enum": [
        "director",
        "ceo",
        "cfo",
        "coo",
        "cto",
        "chief_medical_officer",
        "chief_scientific_officer",
        "vp",
        "officer",
        "ten_percent_owner",
        "other"
      ],
      "example": "ceo"
    },
    "institutional_investor": {
      "type": "string",
      "description": "Name of institutional investor (for Form 13F)",
      "example": "Vanguard Group Inc."
    },
    "investor_type": {
      "type": "string",
      "description": "Type of institutional investor",
      "enum": [
        "hedge_fund",
        "mutual_fund",
        "pension_fund",
        "venture_capital",
        "private_equity",
        "family_office",
        "sovereign_wealth",
        "other"
      ],
      "example": "hedge_fund"
    },
    "transaction_code": {
      "type": "string",
      "description": "SEC transaction code",
      "enum": ["P", "S", "A", "D", "F", "M", "G", "C", "I", "J", "K", "L", "W", "X"],
      "example": "P"
    },
    "shares_transacted": {
      "type": "integer",
      "description": "Number of shares bought/sold",
      "minimum": 0,
      "example": 50000
    },
    "price_per_share": {
      "type": "number",
      "description": "Price per share (USD)",
      "minimum": 0,
      "example": 45.50
    },
    "total_value": {
      "type": "number",
      "description": "Total transaction value (USD)",
      "minimum": 0,
      "example": 2275000
    },
    "shares_owned_after": {
      "type": "integer",
      "description": "Total shares owned after transaction",
      "minimum": 0,
      "example": 250000
    },
    "ownership_percentage": {
      "type": "number",
      "description": "Percentage ownership after transaction",
      "minimum": 0,
      "maximum": 100,
      "example": 2.5
    },
    "ownership_change_percentage": {
      "type": "number",
      "description": "Change in ownership percentage",
      "example": 0.5
    },
    "is_derivative": {
      "type": "boolean",
      "description": "Whether transaction involves derivative securities",
      "example": false
    },
    "impact_score": {
      "type": "number",
      "description": "Calculated impact score (0-100) indicating M&A signal strength",
      "minimum": 0,
      "maximum": 100,
      "example": 75.0
    },
    "signal_strength": {
      "type": "string",
      "description": "Signal strength interpretation",
      "enum": ["strong_buy_signal", "moderate_buy_signal", "neutral", "moderate_sell_signal", "strong_sell_signal"],
      "example": "strong_buy_signal"
    },
    "filing_url": {
      "type": "string",
      "format": "uri",
      "description": "URL to SEC filing",
      "example": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001234567"
    },
    "notes": {
      "type": "string",
      "description": "Additional context or observations",
      "maxLength": 1000
    }
  }
}
```

#### Example Payload

```json
{
  "company_id": "COMP-12345",
  "company_name": "Acme Therapeutics Inc.",
  "ticker_symbol": "ACME",
  "activity_type": "insider_buy",
  "filing_type": "form_4",
  "filing_date": "2025-12-05",
  "transaction_date": "2025-12-03",
  "insider_name": "John Smith",
  "insider_title": "Chief Executive Officer",
  "insider_relationship": "ceo",
  "transaction_code": "P",
  "shares_transacted": 50000,
  "price_per_share": 45.50,
  "total_value": 2275000,
  "shares_owned_after": 250000,
  "ownership_percentage": 2.5,
  "ownership_change_percentage": 0.5,
  "is_derivative": false,
  "impact_score": 75.0,
  "signal_strength": "strong_buy_signal",
  "filing_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001234567",
  "notes": "CEO significant open market purchase following patent cliff announcement. Potential confidence signal."
}
```

---

### HiringSignalEvent

Emitted when key executive or scientific talent movements are detected through job postings, LinkedIn, or other sources.

#### Schema Version: 1.0.0

```json
{
  "$schema": "http://json-schema.org/draft-07/schema#",
  "type": "object",
  "required": [
    "company_id",
    "company_name",
    "signal_type",
    "role_title",
    "signal_date",
    "impact_score"
  ],
  "properties": {
    "company_id": {
      "type": "string",
      "description": "Unique identifier for the company",
      "example": "COMP-12345"
    },
    "company_name": {
      "type": "string",
      "description": "Name of the company",
      "example": "Acme Therapeutics Inc."
    },
    "ticker_symbol": {
      "type": "string",
      "description": "Stock ticker symbol (if publicly traded)",
      "pattern": "^[A-Z]{1,5}$",
      "example": "ACME"
    },
    "signal_type": {
      "type": "string",
      "description": "Type of hiring signal",
      "enum": [
        "executive_hire",
        "executive_departure",
        "scientist_hire",
        "scientist_departure",
        "mass_hiring",
        "hiring_freeze",
        "layoff_announced",
        "job_posting_surge",
        "c_suite_turnover"
      ],
      "example": "executive_hire"
    },
    "role_title": {
      "type": "string",
      "description": "Job title or role",
      "example": "Chief Business Development Officer"
    },
    "role_category": {
      "type": "string",
      "description": "Category of role",
      "enum": [
        "c_suite",
        "vp_level",
        "director_level",
        "principal_scientist",
        "senior_scientist",
        "business_development",
        "regulatory_affairs",
        "clinical_operations",
        "manufacturing",
        "other"
      ],
      "example": "c_suite"
    },
    "person_name": {
      "type": "string",
      "description": "Name of person hired/departed (if known)",
      "example": "Jane Doe"
    },
    "previous_company": {
      "type": "string",
      "description": "Previous company (for hires)",
      "example": "Big Pharma Corp"
    },
    "previous_role": {
      "type": "string",
      "description": "Previous role title",
      "example": "VP of Corporate Development"
    },
    "destination_company": {
      "type": "string",
      "description": "Destination company (for departures)",
      "example": "Competitor Biotech Inc."
    },
    "signal_date": {
      "type": "string",
      "format": "date",
      "description": "Date when signal was detected",
      "example": "2025-12-04"
    },
    "effective_date": {
      "type": "string",
      "format": "date",
      "description": "Effective date of hire/departure",
      "example": "2025-12-15"
    },
    "department": {
      "type": "string",
      "description": "Department or functional area",
      "example": "Business Development"
    },
    "location": {
      "type": "string",
      "description": "Job location",
      "example": "Boston, MA"
    },
    "remote_status": {
      "type": "string",
      "enum": ["on_site", "hybrid", "remote"],
      "example": "hybrid"
    },
    "number_of_positions": {
      "type": "integer",
      "description": "Number of open positions (for mass hiring signals)",
      "minimum": 1,
      "example": 1
    },
    "expertise_areas": {
      "type": "array",
      "description": "Areas of expertise relevant to the role",
      "items": {
        "type": "string"
      },
      "example": ["M&A", "Licensing", "Strategic Partnerships"]
    },
    "impact_score": {
      "type": "number",
      "description": "Calculated impact score (0-100) indicating M&A signal strength",
      "minimum": 0,
      "maximum": 100,
      "example": 82.0
    },
    "signal_interpretation": {
      "type": "string",
      "description": "Interpretation of what this signal may indicate",
      "enum": [
        "preparing_for_acquisition",
        "growth_mode",
        "restructuring",
        "financial_distress",
        "strategic_pivot",
        "normal_turnover",
        "expansion"
      ],
      "example": "preparing_for_acquisition"
    },
    "data_source": {
      "type": "string",
      "description": "Source of the hiring information",
      "example": "LinkedIn Jobs, Company Press Release"
    },
    "source_url": {
      "type": "string",
      "format": "uri",
      "description": "URL to source information",
      "example": "https://www.linkedin.com/jobs/view/1234567890"
    },
    "notes": {
      "type": "string",
      "description": "Additional context or observations",
      "maxLength": 1000
    }
  }
}
```

#### Example Payload

```json
{
  "company_id": "COMP-12345",
  "company_name": "Acme Therapeutics Inc.",
  "ticker_symbol": "ACME",
  "signal_type": "executive_hire",
  "role_title": "Chief Business Development Officer",
  "role_category": "c_suite",
  "person_name": "Jane Doe",
  "previous_company": "Big Pharma Corp",
  "previous_role": "VP of Corporate Development",
  "signal_date": "2025-12-04",
  "effective_date": "2025-12-15",
  "department": "Business Development",
  "location": "Boston, MA",
  "remote_status": "hybrid",
  "number_of_positions": 1,
  "expertise_areas": ["M&A", "Licensing", "Strategic Partnerships"],
  "impact_score": 82.0,
  "signal_interpretation": "preparing_for_acquisition",
  "data_source": "LinkedIn Jobs, Company Press Release",
  "source_url": "https://www.linkedin.com/jobs/view/1234567890",
  "notes": "New CBDO with strong M&A background from major pharma. Potential signal of sale preparation."
}
```

---

### MACandidateEvent

Emitted when a company is flagged as a potential M&A acquisition target based on aggregated signals.

#### Schema Version: 1.0.0

```json
{
  "$schema": "http://json-schema.org/draft-07/schema#",
  "type": "object",
  "required": [
    "candidate_id",
    "company_id",
    "company_name",
    "ma_probability_score",
    "confidence_level",
    "signal_summary",
    "evaluation_date"
  ],
  "properties": {
    "candidate_id": {
      "type": "string",
      "description": "Unique identifier for this M&A candidate assessment",
      "example": "CAND-2025-001"
    },
    "company_id": {
      "type": "string",
      "description": "Unique identifier for the company",
      "example": "COMP-12345"
    },
    "company_name": {
      "type": "string",
      "description": "Name of the candidate company",
      "example": "Acme Therapeutics Inc."
    },
    "ticker_symbol": {
      "type": "string",
      "description": "Stock ticker symbol (if publicly traded)",
      "pattern": "^[A-Z]{1,5}$",
      "example": "ACME"
    },
    "ma_probability_score": {
      "type": "number",
      "description": "Calculated probability score (0-100) that company will be acquired",
      "minimum": 0,
      "maximum": 100,
      "example": 87.5
    },
    "confidence_level": {
      "type": "string",
      "description": "Confidence level in the prediction",
      "enum": ["very_high", "high", "medium", "low"],
      "example": "high"
    },
    "evaluation_date": {
      "type": "string",
      "format": "date",
      "description": "Date when evaluation was performed",
      "example": "2025-12-07"
    },
    "signal_summary": {
      "type": "object",
      "description": "Summary of contributing signals",
      "required": ["clinical_signals", "patent_signals", "insider_signals", "hiring_signals"],
      "properties": {
        "clinical_signals": {
          "type": "object",
          "properties": {
            "count": {
              "type": "integer",
              "minimum": 0
            },
            "average_impact": {
              "type": "number",
              "minimum": 0,
              "maximum": 100
            },
            "key_events": {
              "type": "array",
              "items": {
                "type": "string"
              }
            }
          }
        },
        "patent_signals": {
          "type": "object",
          "properties": {
            "count": {
              "type": "integer",
              "minimum": 0
            },
            "average_impact": {
              "type": "number",
              "minimum": 0,
              "maximum": 100
            },
            "key_events": {
              "type": "array",
              "items": {
                "type": "string"
              }
            }
          }
        },
        "insider_signals": {
          "type": "object",
          "properties": {
            "count": {
              "type": "integer",
              "minimum": 0
            },
            "average_impact": {
              "type": "number",
              "minimum": 0,
              "maximum": 100
            },
            "key_events": {
              "type": "array",
              "items": {
                "type": "string"
              }
            }
          }
        },
        "hiring_signals": {
          "type": "object",
          "properties": {
            "count": {
              "type": "integer",
              "minimum": 0
            },
            "average_impact": {
              "type": "number",
              "minimum": 0,
              "maximum": 100
            },
            "key_events": {
              "type": "array",
              "items": {
                "type": "string"
              }
            }
          }
        }
      }
    },
    "contributing_event_ids": {
      "type": "array",
      "description": "Event IDs that contributed to this M&A candidate assessment",
      "items": {
        "type": "string",
        "pattern": "^[0-9a-f]{8}-[0-9a-f]{4}-4[0-9a-f]{3}-[89ab][0-9a-f]{3}-[0-9a-f]{12}$"
      },
      "example": [
        "550e8400-e29b-41d4-a716-446655440000",
        "660e8400-e29b-41d4-a716-446655440111"
      ]
    },
    "primary_drivers": {
      "type": "array",
      "description": "Primary factors driving M&A likelihood",
      "items": {
        "type": "string",
        "enum": [
          "patent_cliff",
          "clinical_success",
          "clinical_failure",
          "cash_burn",
          "insider_buying",
          "leadership_changes",
          "strategic_hiring",
          "market_conditions",
          "competitive_pressure",
          "regulatory_pressure"
        ]
      },
      "example": ["patent_cliff", "strategic_hiring"]
    },
    "company_financials": {
      "type": "object",
      "description": "Key financial metrics",
      "properties": {
        "market_cap_usd": {
          "type": "number",
          "description": "Market capitalization in USD millions",
          "example": 450.5
        },
        "cash_position_usd": {
          "type": "number",
          "description": "Cash and equivalents in USD millions",
          "example": 85.2
        },
        "quarterly_burn_rate_usd": {
          "type": "number",
          "description": "Quarterly cash burn in USD millions",
          "example": 22.5
        },
        "runway_months": {
          "type": "integer",
          "description": "Estimated cash runway in months",
          "example": 15
        },
        "debt_usd": {
          "type": "number",
          "description": "Total debt in USD millions",
          "example": 50.0
        }
      }
    },
    "pipeline_overview": {
      "type": "object",
      "description": "Summary of drug pipeline",
      "properties": {
        "total_assets": {
          "type": "integer",
          "minimum": 0,
          "example": 5
        },
        "phase3_assets": {
          "type": "integer",
          "minimum": 0,
          "example": 1
        },
        "phase2_assets": {
          "type": "integer",
          "minimum": 0,
          "example": 2
        },
        "phase1_assets": {
          "type": "integer",
          "minimum": 0,
          "example": 2
        },
        "lead_asset": {
          "type": "string",
          "example": "ACM-2001"
        },
        "lead_indication": {
          "type": "string",
          "example": "Non-Small Cell Lung Cancer"
        }
      }
    },
    "therapeutic_focus": {
      "type": "array",
      "description": "Primary therapeutic areas",
      "items": {
        "type": "string"
      },
      "example": ["oncology", "immunology"]
    },
    "technology_platform": {
      "type": "array",
      "description": "Core technology platforms",
      "items": {
        "type": "string"
      },
      "example": ["small molecule", "antibody-drug conjugate"]
    },
    "estimated_valuation_range": {
      "type": "object",
      "description": "Estimated acquisition valuation range",
      "properties": {
        "low_usd": {
          "type": "number",
          "description": "Low estimate in USD millions",
          "example": 800
        },
        "high_usd": {
          "type": "number",
          "description": "High estimate in USD millions",
          "example": 1500
        },
        "basis": {
          "type": "string",
          "description": "Basis for valuation estimate",
          "example": "Comparable transactions, DCF analysis"
        }
      }
    },
    "timeline_estimate": {
      "type": "object",
      "description": "Estimated timeline for potential acquisition",
      "properties": {
        "earliest_date": {
          "type": "string",
          "format": "date",
          "example": "2026-03-01"
        },
        "most_likely_date": {
          "type": "string",
          "format": "date",
          "example": "2026-06-30"
        },
        "latest_date": {
          "type": "string",
          "format": "date",
          "example": "2026-12-31"
        }
      }
    },
    "risk_factors": {
      "type": "array",
      "description": "Key risk factors that could prevent acquisition",
      "items": {
        "type": "string"
      },
      "example": [
        "Clinical trial failure risk",
        "High valuation expectations",
        "Competitive bidding scenario"
      ]
    },
    "notes": {
      "type": "string",
      "description": "Additional analysis and context",
      "maxLength": 2000
    }
  }
}
```

#### Example Payload

```json
{
  "candidate_id": "CAND-2025-001",
  "company_id": "COMP-12345",
  "company_name": "Acme Therapeutics Inc.",
  "ticker_symbol": "ACME",
  "ma_probability_score": 87.5,
  "confidence_level": "high",
  "evaluation_date": "2025-12-07",
  "signal_summary": {
    "clinical_signals": {
      "count": 3,
      "average_impact": 85.0,
      "key_events": [
        "Phase 3 advancement for ACM-2001",
        "Positive interim analysis"
      ]
    },
    "patent_signals": {
      "count": 2,
      "average_impact": 92.0,
      "key_events": [
        "Primary patent expiring Q1 2026",
        "67.5% revenue at risk"
      ]
    },
    "insider_signals": {
      "count": 1,
      "average_impact": 75.0,
      "key_events": [
        "CEO significant open market purchase"
      ]
    },
    "hiring_signals": {
      "count": 1,
      "average_impact": 82.0,
      "key_events": [
        "New CBDO with M&A background hired"
      ]
    }
  },
  "contributing_event_ids": [
    "550e8400-e29b-41d4-a716-446655440000",
    "660e8400-e29b-41d4-a716-446655440111",
    "770e8400-e29b-41d4-a716-446655440222",
    "880e8400-e29b-41d4-a716-446655440333"
  ],
  "primary_drivers": ["patent_cliff", "strategic_hiring"],
  "company_financials": {
    "market_cap_usd": 450.5,
    "cash_position_usd": 85.2,
    "quarterly_burn_rate_usd": 22.5,
    "runway_months": 15,
    "debt_usd": 50.0
  },
  "pipeline_overview": {
    "total_assets": 5,
    "phase3_assets": 1,
    "phase2_assets": 2,
    "phase1_assets": 2,
    "lead_asset": "ACM-2001",
    "lead_indication": "Non-Small Cell Lung Cancer"
  },
  "therapeutic_focus": ["oncology", "immunology"],
  "technology_platform": ["small molecule", "antibody-drug conjugate"],
  "estimated_valuation_range": {
    "low_usd": 800,
    "high_usd": 1500,
    "basis": "Comparable transactions, DCF analysis"
  },
  "timeline_estimate": {
    "earliest_date": "2026-03-01",
    "most_likely_date": "2026-06-30",
    "latest_date": "2026-12-31"
  },
  "risk_factors": [
    "Clinical trial failure risk",
    "High valuation expectations",
    "Competitive bidding scenario"
  ],
  "notes": "Strong M&A candidate driven by imminent patent cliff and strategic positioning moves. Company appears to be preparing for sale with key BD hire. Phase 3 asset provides compelling acquisition rationale for larger pharma seeking oncology portfolio expansion."
}
```

---

### AcquirerMatchEvent

Emitted when a potential acquirer-target pairing is identified based on strategic fit, therapeutic alignment, and historical patterns.

#### Schema Version: 1.0.0

```json
{
  "$schema": "http://json-schema.org/draft-07/schema#",
  "type": "object",
  "required": [
    "match_id",
    "target_company_id",
    "target_company_name",
    "acquirer_company_id",
    "acquirer_company_name",
    "match_score",
    "strategic_rationale",
    "evaluation_date"
  ],
  "properties": {
    "match_id": {
      "type": "string",
      "description": "Unique identifier for this match",
      "example": "MATCH-2025-001"
    },
    "target_company_id": {
      "type": "string",
      "description": "Identifier for the acquisition target",
      "example": "COMP-12345"
    },
    "target_company_name": {
      "type": "string",
      "description": "Name of the target company",
      "example": "Acme Therapeutics Inc."
    },
    "target_ticker_symbol": {
      "type": "string",
      "description": "Target stock ticker symbol",
      "pattern": "^[A-Z]{1,5}$",
      "example": "ACME"
    },
    "acquirer_company_id": {
      "type": "string",
      "description": "Identifier for the potential acquirer",
      "example": "COMP-67890"
    },
    "acquirer_company_name": {
      "type": "string",
      "description": "Name of the potential acquirer",
      "example": "Global Pharma Corporation"
    },
    "acquirer_ticker_symbol": {
      "type": "string",
      "description": "Acquirer stock ticker symbol",
      "pattern": "^[A-Z]{1,5}$",
      "example": "GPC"
    },
    "match_score": {
      "type": "number",
      "description": "Overall match quality score (0-100)",
      "minimum": 0,
      "maximum": 100,
      "example": 89.5
    },
    "evaluation_date": {
      "type": "string",
      "format": "date",
      "description": "Date when match evaluation was performed",
      "example": "2025-12-07"
    },
    "strategic_rationale": {
      "type": "object",
      "description": "Strategic reasons for the match",
      "required": ["primary_rationale", "supporting_factors"],
      "properties": {
        "primary_rationale": {
          "type": "string",
          "description": "Main strategic driver",
          "enum": [
            "pipeline_gap_fill",
            "therapeutic_area_expansion",
            "technology_acquisition",
            "geographic_expansion",
            "defensive_acquisition",
            "talent_acquisition",
            "portfolio_diversification",
            "manufacturing_capacity",
            "market_share_consolidation"
          ],
          "example": "pipeline_gap_fill"
        },
        "supporting_factors": {
          "type": "array",
          "description": "Additional supporting factors",
          "items": {
            "type": "string"
          },
          "example": [
            "Therapeutic area alignment",
            "Phase 3 asset de-risks acquisition",
            "Historical acquisition pattern match"
          ]
        }
      }
    },
    "therapeutic_alignment": {
      "type": "object",
      "description": "Therapeutic area fit analysis",
      "properties": {
        "alignment_score": {
          "type": "number",
          "minimum": 0,
          "maximum": 100,
          "example": 95.0
        },
        "overlapping_areas": {
          "type": "array",
          "items": {
            "type": "string"
          },
          "example": ["oncology"]
        },
        "complementary_areas": {
          "type": "array",
          "items": {
            "type": "string"
          },
          "example": ["immunology"]
        },
        "acquirer_gaps": {
          "type": "array",
          "description": "Therapeutic gaps this acquisition would fill",
          "items": {
            "type": "string"
          },
          "example": ["NSCLC pipeline gap in late-stage"]
        }
      }
    },
    "technology_fit": {
      "type": "object",
      "description": "Technology platform alignment",
      "properties": {
        "fit_score": {
          "type": "number",
          "minimum": 0,
          "maximum": 100,
          "example": 85.0
        },
        "platform_overlap": {
          "type": "array",
          "items": {
            "type": "string"
          },
          "example": ["small molecule"]
        },
        "platform_expansion": {
          "type": "array",
          "items": {
            "type": "string"
          },
          "example": ["antibody-drug conjugate"]
        }
      }
    },
    "financial_fit": {
      "type": "object",
      "description": "Financial compatibility analysis",
      "properties": {
        "fit_score": {
          "type": "number",
          "minimum": 0,
          "maximum": 100,
          "example": 90.0
        },
        "target_valuation_usd": {
          "type": "number",
          "description": "Estimated target valuation in USD millions",
          "example": 1200
        },
        "acquirer_market_cap_usd": {
          "type": "number",
          "description": "Acquirer market cap in USD millions",
          "example": 45000
        },
        "deal_size_percentage": {
          "type": "number",
          "description": "Deal size as percentage of acquirer market cap",
          "example": 2.67
        },
        "acquirer_cash_position_usd": {
          "type": "number",
          "description": "Acquirer cash position in USD millions",
          "example": 8500
        },
        "financing_feasibility": {
          "type": "string",
          "enum": ["highly_feasible", "feasible", "challenging", "unlikely"],
          "example": "highly_feasible"
        }
      }
    },
    "historical_precedent": {
      "type": "object",
      "description": "Historical acquisition pattern analysis",
      "properties": {
        "precedent_score": {
          "type": "number",
          "minimum": 0,
          "maximum": 100,
          "example": 78.0
        },
        "acquirer_deal_history": {
          "type": "object",
          "properties": {
            "total_deals_5y": {
              "type": "integer",
              "example": 12
            },
            "average_deal_size_usd": {
              "type": "number",
              "example": 1500
            },
            "preferred_stages": {
              "type": "array",
              "items": {
                "type": "string"
              },
              "example": ["phase2", "phase3"]
            },
            "preferred_therapeutics": {
              "type": "array",
              "items": {
                "type": "string"
              },
              "example": ["oncology", "rare_disease"]
            }
          }
        },
        "comparable_deals": {
          "type": "array",
          "description": "Similar historical transactions",
          "items": {
            "type": "object",
            "properties": {
              "date": {
                "type": "string",
                "format": "date"
              },
              "target": {
                "type": "string"
              },
              "acquirer": {
                "type": "string"
              },
              "value_usd": {
                "type": "number"
              },
              "similarity_score": {
                "type": "number"
              }
            }
          }
        }
      }
    },
    "synergies": {
      "type": "array",
      "description": "Identified potential synergies",
      "items": {
        "type": "object",
        "properties": {
          "synergy_type": {
            "type": "string",
            "enum": [
              "revenue_synergy",
              "cost_synergy",
              "rd_synergy",
              "commercial_synergy",
              "manufacturing_synergy",
              "regulatory_synergy"
            ]
          },
          "description": {
            "type": "string"
          },
          "estimated_value_usd": {
            "type": "number"
          }
        }
      }
    },
    "risks": {
      "type": "array",
      "description": "Key risks to deal completion",
      "items": {
        "type": "object",
        "properties": {
          "risk_type": {
            "type": "string",
            "enum": [
              "regulatory_risk",
              "antitrust_risk",
              "integration_risk",
              "clinical_risk",
              "valuation_risk",
              "competitive_bid_risk",
              "financing_risk"
            ]
          },
          "description": {
            "type": "string"
          },
          "severity": {
            "type": "string",
            "enum": ["low", "medium", "high", "critical"]
          }
        }
      }
    },
    "probability_estimate": {
      "type": "number",
      "description": "Estimated probability (0-100) of deal occurring within 18 months",
      "minimum": 0,
      "maximum": 100,
      "example": 45.0
    },
    "timeline_estimate": {
      "type": "object",
      "description": "Estimated deal timeline",
      "properties": {
        "earliest_announcement": {
          "type": "string",
          "format": "date",
          "example": "2026-01-01"
        },
        "most_likely_announcement": {
          "type": "string",
          "format": "date",
          "example": "2026-04-15"
        },
        "latest_announcement": {
          "type": "string",
          "format": "date",
          "example": "2026-09-30"
        }
      }
    },
    "confidence_level": {
      "type": "string",
      "description": "Confidence in the match prediction",
      "enum": ["very_high", "high", "medium", "low"],
      "example": "high"
    },
    "ma_candidate_event_id": {
      "type": "string",
      "description": "Reference to the MACandidateEvent that triggered this match",
      "pattern": "^[0-9a-f]{8}-[0-9a-f]{4}-4[0-9a-f]{3}-[89ab][0-9a-f]{3}-[0-9a-f]{12}$"
    },
    "notes": {
      "type": "string",
      "description": "Additional analysis and context",
      "maxLength": 2000
    }
  }
}
```

#### Example Payload

```json
{
  "match_id": "MATCH-2025-001",
  "target_company_id": "COMP-12345",
  "target_company_name": "Acme Therapeutics Inc.",
  "target_ticker_symbol": "ACME",
  "acquirer_company_id": "COMP-67890",
  "acquirer_company_name": "Global Pharma Corporation",
  "acquirer_ticker_symbol": "GPC",
  "match_score": 89.5,
  "evaluation_date": "2025-12-07",
  "strategic_rationale": {
    "primary_rationale": "pipeline_gap_fill",
    "supporting_factors": [
      "Therapeutic area alignment",
      "Phase 3 asset de-risks acquisition",
      "Historical acquisition pattern match"
    ]
  },
  "therapeutic_alignment": {
    "alignment_score": 95.0,
    "overlapping_areas": ["oncology"],
    "complementary_areas": ["immunology"],
    "acquirer_gaps": ["NSCLC pipeline gap in late-stage"]
  },
  "technology_fit": {
    "fit_score": 85.0,
    "platform_overlap": ["small molecule"],
    "platform_expansion": ["antibody-drug conjugate"]
  },
  "financial_fit": {
    "fit_score": 90.0,
    "target_valuation_usd": 1200,
    "acquirer_market_cap_usd": 45000,
    "deal_size_percentage": 2.67,
    "acquirer_cash_position_usd": 8500,
    "financing_feasibility": "highly_feasible"
  },
  "historical_precedent": {
    "precedent_score": 78.0,
    "acquirer_deal_history": {
      "total_deals_5y": 12,
      "average_deal_size_usd": 1500,
      "preferred_stages": ["phase2", "phase3"],
      "preferred_therapeutics": ["oncology", "rare_disease"]
    },
    "comparable_deals": [
      {
        "date": "2024-06-15",
        "target": "Similar Biotech Corp",
        "acquirer": "Global Pharma Corporation",
        "value_usd": 1400,
        "similarity_score": 85.0
      }
    ]
  },
  "synergies": [
    {
      "synergy_type": "revenue_synergy",
      "description": "Leverage GPC's global commercial infrastructure for ACM-2001 launch",
      "estimated_value_usd": 500
    },
    {
      "synergy_type": "rd_synergy",
      "description": "Combine ADC platform with GPC's biologics expertise",
      "estimated_value_usd": 200
    }
  ],
  "risks": [
    {
      "risk_type": "clinical_risk",
      "description": "Phase 3 trial completion required before deal closure",
      "severity": "medium"
    },
    {
      "risk_type": "competitive_bid_risk",
      "description": "Multiple pharma companies may compete for asset",
      "severity": "medium"
    }
  ],
  "probability_estimate": 45.0,
  "timeline_estimate": {
    "earliest_announcement": "2026-01-01",
    "most_likely_announcement": "2026-04-15",
    "latest_announcement": "2026-09-30"
  },
  "confidence_level": "high",
  "ma_candidate_event_id": "880e8400-e29b-41d4-a716-446655440333",
  "notes": "Strong strategic fit with GPC's oncology portfolio expansion strategy. Target's Phase 3 NSCLC asset addresses known pipeline gap. Patent cliff situation may accelerate seller timeline. Historical pattern suggests GPC comfort with this deal size and stage."
}
```

---

### ReportGeneratedEvent

Emitted when M&A analysis reports are generated for distribution to stakeholders.

#### Schema Version: 1.0.0

```json
{
  "$schema": "http://json-schema.org/draft-07/schema#",
  "type": "object",
  "required": [
    "report_id",
    "report_type",
    "report_title",
    "generation_date",
    "reporting_period",
    "output_format"
  ],
  "properties": {
    "report_id": {
      "type": "string",
      "description": "Unique identifier for the report",
      "example": "RPT-2025-12-001"
    },
    "report_type": {
      "type": "string",
      "description": "Type of report generated",
      "enum": [
        "daily_signal_digest",
        "weekly_candidate_summary",
        "monthly_market_analysis",
        "candidate_deep_dive",
        "acquirer_match_report",
        "sector_analysis",
        "alert_report",
        "executive_summary"
      ],
      "example": "weekly_candidate_summary"
    },
    "report_title": {
      "type": "string",
      "description": "Title of the report",
      "example": "Weekly M&A Candidate Summary - December 2025 Week 1"
    },
    "generation_date": {
      "type": "string",
      "format": "date-time",
      "description": "Date and time when report was generated",
      "example": "2025-12-07T18:30:00.000Z"
    },
    "reporting_period": {
      "type": "object",
      "description": "Time period covered by the report",
      "required": ["start_date", "end_date"],
      "properties": {
        "start_date": {
          "type": "string",
          "format": "date",
          "example": "2025-12-01"
        },
        "end_date": {
          "type": "string",
          "format": "date",
          "example": "2025-12-07"
        }
      }
    },
    "output_format": {
      "type": "array",
      "description": "Output formats generated",
      "items": {
        "type": "string",
        "enum": ["pdf", "html", "json", "xlsx", "markdown"]
      },
      "example": ["pdf", "html"]
    },
    "report_sections": {
      "type": "array",
      "description": "Sections included in the report",
      "items": {
        "type": "string",
        "enum": [
          "executive_summary",
          "new_candidates",
          "updated_candidates",
          "acquirer_matches",
          "signal_analysis",
          "market_trends",
          "risk_factors",
          "recommendations",
          "appendix"
        ]
      },
      "example": [
        "executive_summary",
        "new_candidates",
        "acquirer_matches"
      ]
    },
    "summary_statistics": {
      "type": "object",
      "description": "Key statistics from the report",
      "properties": {
        "total_candidates": {
          "type": "integer",
          "minimum": 0,
          "example": 12
        },
        "new_candidates": {
          "type": "integer",
          "minimum": 0,
          "example": 3
        },
        "high_probability_candidates": {
          "type": "integer",
          "minimum": 0,
          "example": 5
        },
        "total_matches": {
          "type": "integer",
          "minimum": 0,
          "example": 28
        },
        "new_signals": {
          "type": "integer",
          "minimum": 0,
          "example": 47
        },
        "clinical_signals": {
          "type": "integer",
          "minimum": 0,
          "example": 18
        },
        "patent_signals": {
          "type": "integer",
          "minimum": 0,
          "example": 8
        },
        "insider_signals": {
          "type": "integer",
          "minimum": 0,
          "example": 12
        },
        "hiring_signals": {
          "type": "integer",
          "minimum": 0,
          "example": 9
        }
      }
    },
    "featured_candidates": {
      "type": "array",
      "description": "Top M&A candidates featured in this report",
      "items": {
        "type": "object",
        "properties": {
          "company_id": {
            "type": "string"
          },
          "company_name": {
            "type": "string"
          },
          "ma_probability_score": {
            "type": "number"
          },
          "rank": {
            "type": "integer"
          }
        }
      }
    },
    "featured_matches": {
      "type": "array",
      "description": "Top acquirer-target matches featured in this report",
      "items": {
        "type": "object",
        "properties": {
          "match_id": {
            "type": "string"
          },
          "target_name": {
            "type": "string"
          },
          "acquirer_name": {
            "type": "string"
          },
          "match_score": {
            "type": "number"
          },
          "rank": {
            "type": "integer"
          }
        }
      }
    },
    "distribution_list": {
      "type": "array",
      "description": "Recipients of the report",
      "items": {
        "type": "object",
        "properties": {
          "recipient_id": {
            "type": "string"
          },
          "recipient_name": {
            "type": "string"
          },
          "recipient_email": {
            "type": "string",
            "format": "email"
          },
          "delivery_method": {
            "type": "string",
            "enum": ["email", "portal", "api", "sftp"]
          }
        }
      }
    },
    "file_locations": {
      "type": "array",
      "description": "Storage locations for generated report files",
      "items": {
        "type": "object",
        "properties": {
          "format": {
            "type": "string"
          },
          "path": {
            "type": "string"
          },
          "size_bytes": {
            "type": "integer"
          },
          "url": {
            "type": "string",
            "format": "uri"
          }
        }
      }
    },
    "generation_metadata": {
      "type": "object",
      "description": "Metadata about report generation",
      "properties": {
        "generation_duration_ms": {
          "type": "integer",
          "description": "Time taken to generate report in milliseconds",
          "example": 3456
        },
        "template_version": {
          "type": "string",
          "example": "2.1.0"
        },
        "data_sources": {
          "type": "array",
          "items": {
            "type": "string"
          },
          "example": [
            "clinical-trial-signals",
            "patent-ip-intelligence",
            "insider-hiring-signals"
          ]
        },
        "data_freshness": {
          "type": "string",
          "format": "date-time",
          "description": "Timestamp of most recent data used in report",
          "example": "2025-12-07T17:45:00.000Z"
        }
      }
    },
    "related_event_ids": {
      "type": "array",
      "description": "Event IDs referenced in this report",
      "items": {
        "type": "string",
        "pattern": "^[0-9a-f]{8}-[0-9a-f]{4}-4[0-9a-f]{3}-[89ab][0-9a-f]{3}-[0-9a-f]{12}$"
      }
    },
    "notes": {
      "type": "string",
      "description": "Additional notes about report generation",
      "maxLength": 1000
    }
  }
}
```

#### Example Payload

```json
{
  "report_id": "RPT-2025-12-001",
  "report_type": "weekly_candidate_summary",
  "report_title": "Weekly M&A Candidate Summary - December 2025 Week 1",
  "generation_date": "2025-12-07T18:30:00.000Z",
  "reporting_period": {
    "start_date": "2025-12-01",
    "end_date": "2025-12-07"
  },
  "output_format": ["pdf", "html"],
  "report_sections": [
    "executive_summary",
    "new_candidates",
    "acquirer_matches",
    "signal_analysis"
  ],
  "summary_statistics": {
    "total_candidates": 12,
    "new_candidates": 3,
    "high_probability_candidates": 5,
    "total_matches": 28,
    "new_signals": 47,
    "clinical_signals": 18,
    "patent_signals": 8,
    "insider_signals": 12,
    "hiring_signals": 9
  },
  "featured_candidates": [
    {
      "company_id": "COMP-12345",
      "company_name": "Acme Therapeutics Inc.",
      "ma_probability_score": 87.5,
      "rank": 1
    },
    {
      "company_id": "COMP-23456",
      "company_name": "Beta Biopharma Ltd.",
      "ma_probability_score": 84.2,
      "rank": 2
    }
  ],
  "featured_matches": [
    {
      "match_id": "MATCH-2025-001",
      "target_name": "Acme Therapeutics Inc.",
      "acquirer_name": "Global Pharma Corporation",
      "match_score": 89.5,
      "rank": 1
    }
  ],
  "distribution_list": [
    {
      "recipient_id": "USR-001",
      "recipient_name": "Investment Committee",
      "recipient_email": "ic@investmentfirm.com",
      "delivery_method": "email"
    }
  ],
  "file_locations": [
    {
      "format": "pdf",
      "path": "/reports/2025/12/RPT-2025-12-001.pdf",
      "size_bytes": 2456789,
      "url": "https://storage.example.com/reports/RPT-2025-12-001.pdf"
    },
    {
      "format": "html",
      "path": "/reports/2025/12/RPT-2025-12-001.html",
      "size_bytes": 876543,
      "url": "https://portal.example.com/reports/RPT-2025-12-001"
    }
  ],
  "generation_metadata": {
    "generation_duration_ms": 3456,
    "template_version": "2.1.0",
    "data_sources": [
      "clinical-trial-signals",
      "patent-ip-intelligence",
      "insider-hiring-signals"
    ],
    "data_freshness": "2025-12-07T17:45:00.000Z"
  },
  "related_event_ids": [
    "550e8400-e29b-41d4-a716-446655440000",
    "660e8400-e29b-41d4-a716-446655440111",
    "770e8400-e29b-41d4-a716-446655440222"
  ],
  "notes": "Weekly summary generated successfully. All data sources current as of 5:45 PM UTC."
}
```

---

## Validation Rules

### Global Validation Rules

1. **UUID Format**: All event IDs, correlation IDs, and causation IDs MUST be valid UUID v4 format
2. **Date Formats**: All dates MUST be in ISO 8601 format (YYYY-MM-DD for dates, full ISO 8601 for timestamps)
3. **Score Ranges**: All score fields (impact_score, match_score, etc.) MUST be between 0 and 100 inclusive
4. **Required Fields**: All fields marked as "required" in the schema MUST be present
5. **Enum Values**: All enum fields MUST use only the specified values
6. **String Lengths**: All string fields with maxLength constraints MUST be enforced
7. **Ticker Symbols**: Stock ticker symbols MUST be 1-5 uppercase letters (pattern: ^[A-Z]{1,5}$)
8. **URLs**: All URL fields MUST be valid URIs

### Event-Specific Validation Rules

#### ClinicalTrialSignalEvent
- `trial_nct_id` MUST match pattern ^NCT\d{8}$
- `current_phase` MUST be later than or equal to `previous_phase` when signal_type is "phase_advancement"
- `impact_score` MUST be calculated based on: signal_type, current_phase, therapeutic_area
- `estimated_completion_date` MUST be in the future

#### PatentCliffEvent
- `days_until_expiration` MUST be calculated from current date to `expiration_date`
- `expiration_date` MUST be after `filing_date`
- `revenue_percentage` MUST be between 0 and 100
- `threat_level` MUST align with `days_until_expiration` and `revenue_percentage`

#### InsiderActivityEvent
- `transaction_date` MUST be before or equal to `filing_date`
- `total_value` SHOULD equal `shares_transacted`  `price_per_share` (within rounding tolerance)
- For activity_type "insider_buy", `transaction_code` SHOULD be "P"
- For activity_type "insider_sell", `transaction_code` SHOULD be "S"

#### HiringSignalEvent
- `effective_date` MUST be after or equal to `signal_date`
- For signal_type "executive_hire", `previous_company` SHOULD be provided
- For signal_type "executive_departure", `destination_company` SHOULD be provided

#### MACandidateEvent
- `ma_probability_score` MUST be derived from signal_summary aggregation
- `contributing_event_ids` array MUST contain at least one event ID
- `signal_summary` counts MUST match number of events in `contributing_event_ids`
- `estimated_valuation_range.low_usd` MUST be less than `estimated_valuation_range.high_usd`
- `timeline_estimate.earliest_date`  `timeline_estimate.most_likely_date`  `timeline_estimate.latest_date`

#### AcquirerMatchEvent
- `deal_size_percentage` MUST equal (`target_valuation_usd` / `acquirer_market_cap_usd`)  100
- `match_score` MUST be calculated from therapeutic_alignment, technology_fit, financial_fit, and historical_precedent scores
- `probability_estimate` MUST be between 0 and 100
- `timeline_estimate.earliest_announcement`  `timeline_estimate.most_likely_announcement`  `timeline_estimate.latest_announcement`

#### ReportGeneratedEvent
- `reporting_period.start_date` MUST be before `reporting_period.end_date`
- `generation_date` MUST be after or equal to `reporting_period.end_date`
- At least one `output_format` MUST be specified
- `summary_statistics` counts MUST be non-negative integers

---

## Event Flow

### Signal Collection Flow

```
1. External Data Sources
   
2. Signal Processors (clinical-trial-signals, patent-ip-intelligence, insider-hiring-signals)
   
3. Emit Individual Signal Events (ClinicalTrialSignalEvent, PatentCliffEvent, etc.)
   
4. Event Bus
   
5. Signal Aggregation Service
   
6. Emit MACandidateEvent (when threshold met)
   
7. Matching Engine
   
8. Emit AcquirerMatchEvent
   
9. Report Generator
   
10. Emit ReportGeneratedEvent
```

### Event Correlation

Events SHOULD be correlated using the following pattern:

1. **correlation_id**: Used to group all events related to a single company's M&A journey
2. **causation_id**: Used to link cause-and-effect relationships between events
3. **contributing_event_ids**: Used in MACandidateEvent and AcquirerMatchEvent to reference source signals

Example correlation flow:
```
ClinicalTrialSignalEvent (event_id: A, correlation_id: X)
  
PatentCliffEvent (event_id: B, correlation_id: X)
  
MACandidateEvent (event_id: C, correlation_id: X, contributing_event_ids: [A, B])
  
AcquirerMatchEvent (event_id: D, correlation_id: X, causation_id: C)
```

---

## Version History

| Version | Date | Changes |
|---------|------|---------|
| 1.0.0 | 2025-12-07 | Initial schema specification |

---

## Notes

- All events are immutable once published
- Event versioning follows semantic versioning (MAJOR.MINOR.PATCH)
- Breaking changes to event schemas require MAJOR version increment
- Consumers MUST handle unknown fields gracefully for forward compatibility
- Producers SHOULD NOT send fields not defined in the schema
- All monetary values are in USD unless otherwise specified
- All timestamps are in UTC timezone

---

**End of Event Schema Specifications**
